Supportive Treatment of Chemotherapy-Induced Neutropenia with Biosimilar Filgrastim: the HEXAFIL Non-Interventional Study.

Tesch, H., Indorf, M., Schaller-Kranz, T., 2011.

EMCC / ESMO (Poster 280, Abstract 4025), 308.

Studie: HEXAFIL; Indikation: Supportivtherapie; Jahr: 2011; Veranstaltung: EMCC (ESMO); Journal: -

iOMEDICO AG
Ellen-Gottlieb-Straße 19
79106 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com